Watch or Listen Instantly and Earn Up to 8.00 AMA PRA Category 1 Credits™ and ACEP Category 1 Credit.
New DEA Licensee Requirements Went Into Effect June 27, 2023
An engaging 8-hour DEA required substance use disorder (SUD) training course covering the MATE Act education requirements
Medication Access and Training Expansion (MATE) Act
Applies to most healthcare providers that hold a DEA license
"On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders" ...
"The deadline for satisfying this new training requirement is the date of a practitioner’s next scheduled DEA registration submission—regardless of whether it is an initial registration or a renewal registration—on or after June 27, 2023." Click here for details.
Entrust The Center for Medical Education to provide your DEA license course
- Since 1985, The Center for Medical Education has been providing live and online evidence-based courses to thousands of clinicians every year.
- You'll experience instruction by an energetic and knowledgeable faculty of “been there, done that” physicians who are experts in the recognition and care of substance use disorder (SUD).
- Our 8-hour course covers everything needed by physicians, NPs, PAs, dentists, and podiatrists to meet the DEA requirements. Click here for details.
- The course will update clinicians on the optimal treatment of outpatient pain, how to screen patients for SUD, and how to effectively treat and/or refer these patients.
Get up to speed on the new DEA licensing requirements
Course Topics:
Introduction
- Content Intro and the Opioid Epidemic
- Patient Interview – Anesthesiologist
- Case Studies – OUD Treatment
- Harm Reduction and Therapeutic Alliance
Substance Use Disorders
- SUD: Risk Factors and Validated Screening Tools
- SUD: Diagnosis and Assessment
- Initiation and Management of FDA Approved Medications for SUDs
- Polysubstance Use and Co-Occurring Mental Disorders
- Patient and Family Education on Safety and Overdose Prevention
- New Drug Update
Effective Treatment Planning
- Patient and Relationship-Centered Care for Patients With Substance Use Disorders
- Empowering Patients: Motivational Interviewing and Shared Decision Making
- How Stigma, Trauma, and the Social Determinants of Health Impact SUD and Recovery
- Collaboration to Facilitate Access to Care
- Legal and Ethical Issues Involved in the Care of Patients With SUD
Pain Mgmt. and Substance Misuse
- Assessing the Patient With Acute, Subacute, or Chronic Pain
- How to Develop an Effective Treatment Plan With a Multidisciplinary Approach
- Managing Patients on Opioids and When to Taper Off
- Recognizing Signs of OUD in the Setting of Prescribed Opioids
Applies to most DEA license holders (except veterinarians), including:
Physicians
Physician Assistants
Nurse Practitioners
Dentists
Podiatrists
Meet the Faculty
Experts in the recognition and care of substance use disorder (SUD)
W. Richard Bukata, MD – Course Developer
Roya Caloia, DO, MPH – Course Developer
Jestin Carlson, MD, MS, MHA – Course Developer
Gretchen Fuller, MD
Emily Johnson, MD, MPH
Christopher Johnston, MD
Howard Levitin, MD
Frank LoVecchio, DO, MPH
Jonathan Oskvarek, MD, MBA
Todd Schneberk, MD
Shilp Shah, MD, MPH
Monisha Vasa, MD
Jointly Sponsored by
Self-Study CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical education through the joint providership of the Center for Emergency Medical Education and The Center for Medical Education, Inc. The Center for Emergency Medical Education (CEME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Center for Emergency Medical Education (CEME) designates this self-study activity for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved for 6.00 hours of pharmacology.
Approved by the American College of Emergency Physicians for a maximum of 8 hour(s) of ACEP Category I credit.
The AOA automatically recognizes AMA PRA Category 1 Credit™ as AOA Category 2 credit.
Both PA and NP organizations recognize AMA PRA Category 1 Credit™ as approved CME.
The Center for Medical Education, Inc., is an approved provider by the California Board of Registered Nursing, Provider No. 12345.
Target Audience
This self-study course is intended for DEA-registered practitioners who are renewing their license or any first-time registrants (with the exception of practitioners that are solely veterinarians) to fulfill the DEA 8-hour training requirement on opioid or other substance use disorders, as well as the safe pharmacological management of pain, including dental pain.
Learning Objectives
Upon completion of this self-study program, participants will be able to:
- Explain the general concepts concerning analgesic and controlled substance pharmacology.
- Incorporate strategies to use methods to limit pain that do not involve controlled substances.
- Incorporate strategies to appropriately limit the use of opioids for pain management.
- Identify risks for addiction to controlled substances and signs of occult and apparent addiction.
- Initiate treatment for addiction to opioids or know options for referral for definitive care.